The Claim
Following discontinuation of tirzepatide, 67% of the regained body weight consists of lean mass and 38% consists of fat mass, indicating a preferential restoration of lean tissue over fat tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
After stopping tirzepatide, most of the weight that comes back is muscle, not fat.
See the scientific wording
After tirzepatide discontinuation, 67% of regained weight is lean mass and only 38% is fat mass, indicating that weight regain preferentially restores muscle rather than fat tissue.
After the drug stops, the body keeps building muscle because muscle cells continue to make protein at a high rate, while fat cells lose their ability to store new fat efficiently, so most of the weight that comes back is muscle.
What the research says
1 studyStudy: 1676-P: Changes in Body Composition During and After Weight Loss with Tirzepatide
When people stopped taking tirzepatide, most of the weight they gained back was muscle, not fat — about two-thirds muscle and less than two-fifths fat, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.